Dengue and dengue hemorrhagic fever: A worldwide health problem;Dengue y fiebre hemorrágica del dengue, un problema de salud mundial

Revista Cubana de Medicina Tropical

Volumn 60, Issue 1, 2008, Pages

  Guzmán, María G ^a   García, Gissel ^a   Kourí, Gustavo ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b IPK

Author keywords

Dengue; Disease; Pathogenesis; Remission

Indexed keywords

EID: 47249092445     PISSN: 03750760     EISSN: 15613054     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Sotolongo F. Carlos J. Finlay. Rev Cubana Med Trop. 1973;25:7-20.
2. Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? CIMID. 2004;27:319-30.
3. Monath TP. Yellow fever and dengue- the interactions of virus, vector and host in the re-emergence of epidemic disease. Sem Virol. 1994;5:133-45.
4. Smith CEG. The history of dengue in tropical Asia and its probable relationship to the mosquito Aedes aegypti. J Trop Med Hyg. 1959;59:243-51.
5. Pan American Health Organization. Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control. Washington, D.F.: PAHO; 1994. (Scientific Publication No. 548).
6. Nimmannitya S. Clinical manifestations of dengue/dengue haemorrhagic fever. Monograph on dengue/dengue haemorrhagic fever. World Health Organization. Regional Office for South East Asia, New Delhi: Regional Publication, SEARO No. 22; 1993.
7. Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaard ED. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg. 2001;65:848-51.
8. Nguyen TL, Nguyen TH, Tieu NT. The impact of dengue haemorrhagic fever on liver function. Res Virol. 1997;148:273-7.
9. Rigau JG. Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Rev Panam Salud Publica. 1997;1:381-8.
10. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N. Early clinical and laboratory indicators of acute dengue illness. J Inf Dis. 1997;176:313-21.
11. Chlebicki MP, Ang B, Barkham T, Laude A. Retinal haemorrhages in 4 patients with dengue fever. E Inf Dis 2005;11:770-2.
12. Gonzalez D, Castro OE, Kouri G, Perez J, Martinez E, Vazquez S, et al. Classical dengue hemorrhagic fever from two dengue infections spaced 20 years or more apart. Havana, dengue 3 epidemic 2001-2002. Int J Inf Dis. 2005;9:280-5.
13. Harris E, Videa E, Pérez E, Sandoval E, Téllez Y, Pérez M A. Clinical, epidemiologic and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg. 2000;63:5-11.
14. Guzmán MG, Kourí G, Díaz M, Llop A, Vázquez S, González D, et al. Dengue, one of the great emerging health challenges of the 21st century. Expert Rev Vaccines 2004;3:511-20.
15. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, et al. Structure of dengue virus: implications for flavivirus genome organziation, maturation and fusion. Cell. 2002;108:717-25.
16. Xu T, Sampath A, Chao A, Wen D, Nanao M, Chene P, et al. Structure of the dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A. J Virol. 2005;79:10278-88.
17. Wang E, Ni H, Xu R, Barrett ADT, Warowich SJ, Gubler DJ, et al. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol. 2000;74:3227-34.
18. Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res. 2003;59:315-41.
19. Leitmeyer K, Vaughn D, Watts DM, Salas R, Villalobos de Chacon I, et al. Dengue virus structural differences that correlate with patogénesis. J Virol. 1999;73:4738-47.
20. Cologna R, Armstrong PM, Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol. 2005;79:853-9.
21. Holmes EC, Twiddy SS. The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol 2003;3:19-28.
22. Halstead SB. Antibody, macrophages, dengue virus infection, shock and haemorrhage: a pathogenetic cascade. Rev Infect Dis 1989;11:5830-39.
23. Rothman AL, Ennis FA. Immunopathogenesis of Dengue Hemorrhagic Fever. Virology. 1999;257:1-6.
24. Chaturvedi UC, Agarwak R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol. 2000;28:183-8.
25. Monath TP. Flaviviruses. In: Virology. Fields BN editor. New York:Raven Press; 1996. p. 763-814.
26. Halstead SB, Nimmannitya S, Cohen SN. Observation related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovery. Yale J Biol Med. 1970;42:311-28.
27. Burke DS, Nisalak A, Jhonson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38:172-80.
28. Guzmán MG, Kourí GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba. A retrospective seroepidemiologic study Am J Trop Med Hyg. 1990;42:179-84.
29. Halstead SD. Immune enhancement of viral infection. Prog Allergy. 1982;31:202-9.
30. Kurane I, Janus J, Ennis FA. Dengue virus infection of human skin fibroblasts in vitro production of IFN-β, IL-6 and GM-CSF. Arch Virol. 1992;124:21-30.
31. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38:411-9.
32. Kurane I, Meager A, Ennis FA. Dengue virus specific human T cell clones.Serotype cross reactive proliferation, Gamma interferon production and cytotoxic activity. J Exp Med. 1989;170:763-75.
33. Kurane I, Ennis AF. Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever. Sem Virol 1994;5:443-8.
34. Kurane I, Okamoto Y, Dai LC, Zeng LL, Brington MA, Ennis FA. Flavivirus -cross-reactive, HLA-DR-15- restricted epitope on NS3 recognized by human CD4+ CD8-cytotoxic T lymphocyte clones. J Gen Virol. 1995;76:2243-9.
35. Mathew A, Kurane I, Rothman AL, Zeng LL, Brinton MA, Ennis FA. Dominant recognition by human CD8+ cytotoxic T lymphocyte of dengue virus nonstructural NS3 and NS1a. J Clin Invest. 1996;98:1684-894.
36. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, et al. Activation of T lymphocytes in dengue virus infection . High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gammain sera of children with dengue. J Clin Invest. 1991;88:1473-80.
37. Gagnon SJ, Ennis FA, Rothman AL. Bystander target cell lysis and cytokines production by dengue virus-specific human cytotoxic T lymphocytes clones. J Virology. 1999;73:3623-9.
38. Guzman MG, Kourí G, Valdes L, Bravo J, Vazquez S, Halstead SB. Enhanced severity of secondary dengue 2 infections: deaths rates in 1981 and 1997 Cuban outbreaks. Pan Am J Public Health. 2002;11:223-7.
39. Sierra B, García G, Pérez AB, Morier L, Rodriguez R, Alvarez M, et al. Long term memory cellular immune response to dengue virus after a natural primary infection. Int J Inf Dis. 2002;6:125-8.
40. Guzmán MG, Peláez O, Kourí G, Quintana I, Vázquez S, Pentón M, et al. Caracterización final y lecciones de la epidemia de dengue 3 en Cuba, 2001-2002. Rev Panam Salud Publica. 2006;19:282-9.
41. Halstead SB, Heinz FX, Barrett ADT, Roehrig JT. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine 2005;23:849-56.
42. Chungue E, Polil, Roche C, Gestas P, Glaziov P, Markoff JL. Correlation between detection of plasminogen cross-reactiveantibodies and hemorrhage in dengue virus infection. J Inf Dis. 1994;170:1304-7.
43. Guzmán MG, Kourí G, Halstead S. Do escape mutants explain rapid increases in dengue case fatality rates within epidemics?. Lancet. 2000;355:1902-3.
44. Bielefeldt-Ohmann H. The pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol. 1997;5:409-13.
45. Sierra B, Pérez AB, García G, Sturn-Ramirez K, Obasanjo O, et al. HLA-A, -B, -C, and - DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol. 2007;68(6):531-40.
46. Kourí G, Guzmán MG, Bravo J. Why dengue hemorragic fever in Cuba? An integral analysis. Trans Royal Soc Trop Med Hyg. 1987;81:821-3.
47. Guzmán MG, Álvarez M, Vázquez S, Kourí G. Laboratory diagnosis of dengue infection: epidemiology and field studies. Dengue diagnostic: proceedings of an international workshop. ENICEF/UNDP/World Bank/WHO Special Programme for research and Training in Tropical Diseases (TDR), 4-6 October 2004. Geneva: WHO/TDR: 2005. (TDR/IRM/DIAG/DEN/05.1)
48. Vázquez S, Pérez AB, Ruiz D, Rodríguez R, Pupo M, Calzada N, et al. Serological markers during dengue 3 primary and secondary infections. J Clin Virol. 2005;33:132-7.
49. Guzman MG, Kouri G. Dengue diagnosis, advances and challenges. Int J Inf Dis. 2004;8:69-80.
50. Vazquez S, Cabezas S, Pérez AB, Pupo M, Ruiz D, Calzada N, et al. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. Int J Infect Dis. 2007;11(3):256-62.
51. Rodríguez R, Álvarez M, Guzmán MG, Morier L, Kourí G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J Clin Microbiol. 2000;38:3508-10.
52. Rosario D, Álvarez M, Díaz J, Contreras R, Vázquez S, Rodríguez R, et al. Rapid detection and typing of dengue viruses from clinical samples using reverse transcriptase-polymerase chain reaction. Pan Am J Public Health. 1998;4:1-5.
53. Chutinimitkul S, Payungporn S, Theamboonlers A, Poovorawan Y. Dengue typing assay based on real-time PCR using SYBR Green I. J Virol Methods. 2005;129:8-15.
54. Kittigul L, Meethien N, Sujirarat D, Kittigul C, Vasanavat S. Comparison of dengue virus antigens in sera and peripheral blood mononuclear cells from dengue infected patients. Asian Pacific J Allergy Immunol. 1997;15:187-91.
55. Kumarasamy V, Wahab AH, Chua SK, Hassan Z, Chem YK, Mohamad M, et al. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J Virol Methods. 2007;140(1-2):75-9.
56. Mondesire RR. Commercial kits and reagents. Dengue diagnostic: proceedings of an international workshop. ENICEF/UNDP/World Bank/WHO Special Programme for research and Training in Tropical Diseases (TDR), 4-6 October 2004. Geneva: WHO/TDR; 2005. p. 30-31. (TDR/IRM/DIAG/DEN/05.1, 2005)
57. Guzmán MG, Kourí G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27:1-13.
58. Mackenzie JS, Gubler DJ, Petersen LT. Emerging flaviviruses: the spread and resurgence of Japanese encephalisits, West Nile and dengue viruses. Nature Med. 2004;10:S98-A109.
59. Melzert MI, Rigau JG, Clark GG, Reiter P, Gubler DJ. Using disability adjusted life years to asses the economic impact of dengue in Puerto Rico: 1984-1994. Am J Trop Med Hyg. 1998;59:265-71.
60. Rudnick A. Ecology of dengue virus. Asian J Infect Dis. 1978;2:156-60.
61. Guzmán MG, Mune M, Kourí G. Dengue vaccine: priorities and progress. Expert Rev Anti Infect Ther. 2004;2:1-17.